BGMD

BG Medicine (CE) (BGMD)

BG Medicine Inc (CE)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:BGMD

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2016/06/28	03 : 14	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:BGMD	BG Medicine Inc (CE)
2016/06/23	21 : 16	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:BGMD	BG Medicine Inc (CE)
2016/05/06	05 : 20	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	USOTC:BGMD	BG Medicine Inc (CE)
2016/05/05	07 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BGMD	BG Medicine Inc (CE)
2016/05/05	00 : 14	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	USOTC:BGMD	BG Medicine Inc (CE)
2016/04/30	05 : 30	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	USOTC:BGMD	BG Medicine Inc (CE)
2016/04/05	06 : 02	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:BGMD	BG Medicine Inc (CE)
2016/04/01	19 : 01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:BGMD	BG Medicine Inc (CE)
2016/04/01	06 : 18	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:BGMD	BG Medicine Inc (CE)
2016/03/30	03 : 52	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:BGMD	BG Medicine Inc (CE)
2016/03/30	03 : 50	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:BGMD	BG Medicine Inc (CE)
2016/03/30	03 : 48	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:BGMD	BG Medicine Inc (CE)
2016/03/30	03 : 45	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:BGMD	BG Medicine Inc (CE)
2016/03/30	03 : 43	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:BGMD	BG Medicine Inc (CE)
2016/03/30	03 : 39	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:BGMD	BG Medicine Inc (CE)
2016/03/30	03 : 37	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:BGMD	BG Medicine Inc (CE)
2016/03/30	03 : 33	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:BGMD	BG Medicine Inc (CE)
2016/01/20	06 : 04	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:BGMD	BG Medicine Inc (CE)
2015/12/23	21 : 58	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:BGMD	BG Medicine Inc (CE)
2015/12/12	06 : 24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BGMD	BG Medicine Inc (CE)
2015/12/05	07 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:BGMD	BG Medicine Inc (CE)
2015/11/30	21 : 50	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:BGMD	BG Medicine Inc (CE)
2015/11/25	04 : 20	Edgar (US Regulatory)	(25-NSE/A)	USOTC:BGMD	BG Medicine Inc (CE)
2015/11/24	23 : 48	Edgar (US Regulatory)	(25-NSE)	USOTC:BGMD	BG Medicine Inc (CE)
2015/11/24	06 : 25	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:BGMD	BG Medicine Inc (CE)
2015/11/21	07 : 50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BGMD	BG Medicine Inc (CE)
2015/11/21	07 : 48	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BGMD	BG Medicine Inc (CE)
2015/11/21	07 : 45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BGMD	BG Medicine Inc (CE)
2015/11/21	07 : 41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BGMD	BG Medicine Inc (CE)
2015/11/21	07 : 35	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:BGMD	BG Medicine Inc (CE)